In future research, it will be important to probe the effects of mAb 99D on tau pathology in the gut ENS of tauopathy/AD models and to determine whether such effects precede and/or affect tau accumulation and AD pathology in the CNS. This evidence concerns the gene MAPT and tauopathy.